eISSN: 2345-6558

Free Access

Journal of Parathyroid Disease 2018;6(2):80-86 doi: 10.15171/jpd.2018.26
Cinacalcet therapy for achievement of the NKF/K-DOQITM clinical practice guidelines for bone and mineral metabolism in individuals under regular hemodialysis

Original

Taoufiq Aatif 1 * , Najet El Esper 2, Philippe Moriniere 2, Gabriel Choukroun 2, Albert Fournier 2

1 Nephrology Department, 5th Military Hospital, Guelmim, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fes, Morocco.
2 Nephrology Department, University Hospital Center of Amiens, France.


*Corresponding author: Taoufiq Aatif, Email:
Email: taoufiq.aatif@usmba.ac.ma


Abstract

Introduction: Cinacalcet (CNL) suppresses the secretion of parathyroid hormone (PTH).

Objective: To consider the effect of CNL administration on achievement of K/DOQITM (Kidney Disease Outcomes Quality Initiative) targets in a group of hemodialysis (HD) patients with secondary hyperparathyroidism (SHPT).

Patients and Methods: Patients undergoing HD who had initiated CNL enrolled in the study. Data were collected at the baseline and after 12 months. This data consisted of serum calcium (Ca), phosphorus (P), intact PTH (iPTH), proportion of calcium in dialysate, administered doses of CNL and proportion of administered phosphate binders and proportion of patients attaining K/DOQITM targets were gathered.

Results: Twenty HD patients enrolled in the study. The proportions of individuals attaining K/DOQITM targets at month 12 were 35% for iPTH, 65% for P, 60% for Ca and 80% for Ca×P product, compared with 0%, 45%, 55% and 50% at the baseline respectively. Around 35% of individuals had attained the combined K/DOQITM targets for Ca, P and iPTH compared with 0% at the starting point.

Conclusion: CNL ameliorates attainment of K/DOQITM targets in individuals with SHPT. This result is consistent with findings from other studies.



Notes
Please cite this paper as: Aatif T, El Esper N, Moriniere PH, Choukroun G, Fournier A. Cinacalcet therapy for achievement ofthe NKF/K-DOQI TM clinical practice guidelines for bone and mineral metabolism in individuals under regular hemodialysis. JParathyr Dis. 2018;6(2):80-86. doi: 10.15171/jpd.2018.26.

Comments
First name  
Last name  
Email address  
Comments  
Security code



Article
PDF


Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks

Cite by
Google Scholar

Google Scholar
Articles by Taoufiq Aatif
Articles by Najet El Esper
Articles by Philippe Moriniere
Articles by Gabriel Choukroun
Articles by Albert Fournier
Similar articles
Related articles

PubMed
Articles by Taoufiq Aatif
Articles by Najet El Esper
Articles by Philippe Moriniere
Articles by Gabriel Choukroun
Articles by Albert Fournier


Article Access Statistics
Viewed
PDF Downloaded
Comments

Share this article!
Creative Commons Attribution 4.0 License This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 The Author(s)
Published by Nickan Research Institute